Moolec Science (MLEC) Land & Improvements (2024 - 2025)
Moolec Science's (MLEC) quarterly Land & Improvements came in at $100896.0 in Q2 2025, down 99.32% year-on-year from $14.9 million in Q2 2024, and down 99.32% quarter-over-quarter from $14.9 million in Q2 2024.
Moolec Science (MLEC) Land & Improvements (2024 - 2025) Analysis & Trends
Moolec Science has disclosed Land & Improvements across 2 years of filings, most recently posting $100896.0 for Q2 2025.
- Land & Improvements for Q2 2025 came in at $100896.0, down 99.32% year-over-year; the trailing twelve-month figure through Jun 2025 was $100896.0 (down 99.32% YoY), and the FY2025 annual result was $100896.0, down 99.32% from the prior year.
- Land & Improvements came in at $100896.0 for Q2 2025 at Moolec Science, down from $14.9 million in the prior quarter.
- In the past five years, Land & Improvements ranged from a high of $14.9 million in Q2 2024 to a low of $100896.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Land & Improvements (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 100,896.00 |
| Jun 30, 2024 | 14.92 Mn |